Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539692 · ClinicalTrials.gov registry record
Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site
A clinical trial of Food Allergy, sponsored by Stanford University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03539692: Recruiting study of Food Allergy, sponsored by Stanford University.
NCT03539692 is a study of Food Allergy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 1,000 participants, above the 905-participant average among 17 other Food Allergy trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03539692, a study of Food Allergy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a protocol for prescreening of participants who would like to be in clinical studies in our Center at Stanford.
Primary Outcome
Standardized Oral food challenges will occur in a staged manner to diagnose food allergies
Conditions Studied
Study Locations (1)
California
- The Sean N. Parker Center for Allergy and Asthma Research, Stanford University - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2018-06-10 |
| Est. Completion | 2028-12 |
What NCT03539692 shows while recruiting
NCT03539692 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 905-participant average among 17 other Food Allergy trials with a reported enrollment target (10% higher).
The record links to 1 condition, with Food Allergy appearing as the primary indexed condition, and to 0 interventions.
NCT03539692 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03539692 about?
NCT03539692 is a clinical study titled "Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site". This is a protocol for prescreening of participants who would like to be in clinical studies in our Center at Stanford.
What is the current status of trial NCT03539692?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2018-06-10. Estimated completion is 2028-12.
What conditions does trial NCT03539692 study?
This clinical trial studies the following conditions: Food Allergy.
Who is sponsoring clinical trial NCT03539692?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03539692 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Food Allergy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03539692's enrollment target sits among peer trials
1,000 5th of 17 higher than 13 of 17 other Food Allergy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Food Allergy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Omalizumab in the Skin of Food Allergy Patients
RECRUITING · Phase 4
-
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
RECRUITING
-
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
RECRUITING · Phase 1
-
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
RECRUITING · Phase 2
-
Natural History and Genetics of Food Allergy and Related Conditions
RECRUITING
-
Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI